SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-24-023769
Filing Date
2024-02-14
Accepted
2024-02-14 16:26:23
Documents
2
Group Members
JEREMY C. GREENREDMILE BIOPHARMA INVESTMENTS III, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm245846d3_sc13ga.htm SC 13G/A 98091
2 EXHIBIT 99.1 tm245846d3_ex99-1.htm EX-99.1 7157
  Complete submission text file 0001104659-24-023769.txt   106949
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Filed by) CIK: 0001425738 (see all company filings)

IRS No.: 208592298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Subject) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91585 | Film No.: 24638938
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)